•ReVision Implant secures FDA Breakthrough Device Designation for visual cortical prosthesis•CLI research finds opticians are key to better vision and contact lens care•ZEISS launches Collaborative Care digital app for flexible ECP coordination•Heru debuts PretestPro for its wearable VR-based testing platform•FDA approves J&J's TECNIS PureSee IOL for cataract patients•ReVision Implant secures FDA Breakthrough Device Designation for visual cortical prosthesis•CLI research finds opticians are key to better vision and contact lens care•ZEISS launches Collaborative Care digital app for flexible ECP coordination•Heru debuts PretestPro for its wearable VR-based testing platform•FDA approves J&J's TECNIS PureSee IOL for cataract patients
HEADLINES
FEATURED
Agency notes a lack of substantial evidence, failure to demonstrate efficacy, and inconsistent study results in latest dismissal of the DED eye drop.
Earn FREE CE 24/7 with Courses by Eyes On Eyecare
Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.
